Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of Recurrence After Surgery and Radiation

Congratulations to Dr. Patel – Recipient of the 2025 Elaine H. Snyder Cancer Research Award! 

We are proud to announce that Dr. Patel has been selected as the winner of the Elaine H. Snyder Cancer Research Award, presented annually to the GWU School of Medicine and Health Sciences researcher who has made the most outstanding contribution to cancer research in the past year. As part of this honor, Dr. Patel will receive one year of research funding (approximately $25,000) from the Elaine H. Snyder Endowment to further support and advance his impactful work.

Please join us in congratulating Dr. Patel on this remarkable achievement and his continued dedication to improving outcomes for patients with cancer.

Dr. Vishal Patel Presented at the European Society for Medical Oncology with Dr. Axel Hauschild, Dr. David Miller, and Dr. Marlies Wakkee.

Dr. David Miller and Dr. Vishal Patel co-chaired the Cutaneous Malignancies Forum, a focused session held as part of the Las Vegas Dermatology Seminar 2025.

For surgical or cutaneous oncology referrals, please email skincancer@mfa.gwu.edu with relevant patient information (PHI secure). For patient inquires or appointments, please call Allison Moradel, Cutaneous Oncology program coordinator, at 202-741-2829.